Immunic, Inc. (IMUX) Q2 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Immunic, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:04.472 Good morning and welcome to Munich's second quarter 2023 earnings call. 00:00:04.472 -- 00:00:08.415 My name is Jessica Bru, Head of Investor Relations and Communications at the Munich. 00:00:08.415 -- 00:00:11.136 I will also be the moderator on today's call. 00:00:11.136 -- 00:00:15.619 Speaking on the call are Dr. Daniel Fitt, our Chief Executive Officer and President, 00:00:15.619 -- 00:00:18.842 as well as Glenn Whaley, our Chief Financial Officer. 00:00:18.842 -- 00:00:24.245 Please note that all participants will be in listening mode and this event is being recorded. 00:00:24.245 -- 00:00:28.327 After today's presentation, there will be an opportunity to ask questions. 00:00:28.327 -- 00:00:32.928 If you join the webcast via the Zoom platform, there are two ways to submit your questions. 00:00:32.928 -- 00:00:37.690 You can either submit in writing via the Q&A tool of the Zoom portal, or if you would 00:00:37.690 -- 00:00:41.752 like to speak with us directly, please use the raise hand function of the Zoom portal 00:00:41.752 -- 00:00:44.212 to queue your question. 00:00:44.633 -- 00:00:49.315 Before we begin, I would like to remind you that this presentation may contain forward-looking 00:00:49.315 -- 00:00:55.036 statements. Such statements can be identified by words such as may, will, expect, anticipate, 00:00:55.036 -- 00:00:59.818 estimate, or words with a similar meaning, and such statements involve a number of risks 00:00:59.818 -- 00:01:03.980 and uncertainties that could cause Immunix's actual results to differ materially from 00:01:03.980 -- 00:01:08.583 those discussed here. Please note that these forward-looking statements reflect Immunix's 00:01:08.583 -- 00:01:13.185 opinions only as of the date of this present...